Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)

NCT01939184 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT01939184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01939184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Lead sponsor
Warner Chilcott
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2013
Completion date
April 30, 2014
Enrollment
796 (actual)
Sites
95

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia